Diagnosis Confirmation Model: A Value-Based Pricing Model for Inpatient Novel Antibiotics. (2018)

• Record Type: Journal Article
• Authors: Lum, Ka; Bhatti, Taimur; Holland, Silas; Guthrie, Mark; Sassman, Stephanie
• Editors: Bettiol, Esther; Hackett, Judith; Harbarth, Stephan
• Is Part Of: Journal of law, medicine & ethics. Volume 46(2018)Supplement 1
• Page Start: 66
• Page End: 74
• Publication Date: 2018
• Subjects: Medical laws and legislation -- United States -- Periodicals; Medical care -- Law and legislation -- United States -- Periodicals; Medical ethics -- Periodicals; Jurisprudence -- Periodicals; Legislation, Medical -- Periodicals; Legislation, Nursing -- Periodicals; Ethics -- Periodicals; Forensic Medicine -- Periodicals; Nursing -- Periodicals; Medicine -- Periodicals; Societies -- Periodicals; Medical care -- Law and legislation; Medical ethics; Medical laws and legislation; United States; Periodicals; 344.73041
• DOI: 10.1177/1073110518782917
• Languages: English
• ISSNs: 1073-1105

Abstract

Abstract : The Diagnosis Confirmation Model (DCM) includes a dual-pricing mechanism designed to support value-based pricing of novel antibiotics while improving the alignment of financial incentives with their optimal use in patients at high risk of drug-resistant infections. DCM is a market-based model and complementary to delinked models. Policymakers interested in stimulating antibiotic innovation could consider tailoring the DCM to their reimbursement systems and incorporating it into the suite of incentives to improve the economics of antibiotics.